Cystathionine beta-synthase promotes anoikis resistance and transcoelomic metastasis in ovarian cancer via SP1- ITGB1 regulation

Experimental Hematology & Oncology · Published 2026-07-09 · DOI 10.1186/s40164-026-00808-x

Free full text

Authors (13)

Pallab Shaw, Arpan Dey Bhowmik, Akrit Pran Jaswal, Rameswari Velayutham, Srikanth Chiliveru, Samantha Ricketts, Chao Xu, Danny N. Dhanasekaran, Zhizhaung Joe Zhao, Resham Bhattacharya, Priyabrata Mukherjee, Shailendra Kumar Dhar Dwivedi, Geeta Rao

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Shaw, P., Bhowmik, A., Jaswal, A., et al. (2026). Cystathionine beta-synthase promotes anoikis resistance and transcoelomic metastasis in ovarian cancer via SP1- ITGB1 regulation. Experimental Hematology & Oncology. https://doi.org/10.1186/s40164-026-00808-x

Related articles

• Role of methionine metabolism in cancer: recent advances in molecular mechanisms and therapeutic implications · Experimental Hematology & Oncology · 2026 · Same journal
• Single-cell profiling reveals reprogrammed hierarchy and disrupted immune-stromal ecosystem in TP53-mutated AML · Experimental Hematology & Oncology · 2026 · Same journal
• Autophagy-promoted immunogenic cell death elicited by tyrosine kinase inhibitor orchestrates a synergistic immunotherapeutic microenvironment in hepatocellular carcinoma · Experimental Hematology & Oncology · 2026 · Same journal
• Novel non-viral in vivo CAR-T therapies: latest updates from the 2025 ASH annual meeting · Experimental Hematology & Oncology · 2026 · Same journal
• Stem cell engineering for the generation of allogeneic CAR-directed natural killer T cells targeting endometrial carcinoma · Experimental Hematology & Oncology · 2026 · Same journal
• Methods and applications of patient-derived organoid models for immune microenvironment and immunotherapy research in multiple cancer types · Experimental Hematology & Oncology · 2026 · Same journal
• Functional xenogeneic hematopoietic cells maintaining donor-dominant identity and immune tolerance enable therapy · Experimental Hematology & Oncology · 2026 · Same journal
• Targeting epigenetic methylation: emerging diagnosis and therapeutic strategies in cancer · Experimental Hematology & Oncology · 2026 · Same journal
• Overcoming fratricide of CD86 targeting CAR-T cells by defined logic-gate CAR strategy · Experimental Hematology & Oncology · 2026 · Same journal
• Tertiary lymphoid structures correlate with reduced recurrence risk and enhanced antitumor immunity in esophageal squamous cell carcinoma with pathologic non-complete response to neoadjuvant chemoimmunotherapy · Experimental Hematology & Oncology · 2026 · Same journal